Darunavir/Cobicistat
Brand name: Prezcobix
Rank #158 of 500 drugs by total cost
$99.7M
Total Cost
38,374
Total Claims
$99.7M
Total Cost
1,184
Prescribers
$2,598
Cost per Claim
1,346
Beneficiaries
40,300
30-Day Fills
$84K
Avg Cost/Provider
32
Avg Claims/Provider
About Darunavir/Cobicistat
Darunavir/Cobicistat (sold as Prezcobix) was prescribed 38,374 times by 1,184 Medicare Part D providers in 2023, costing the program $99.7M. At $2,598 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 155 | Nilotinib Hcl (Tasigna) | $100.9M | 6,308 |
| 156 | Quetiapine Fumarate (Quetiapine Fumarate) | $100.9M | 3,820,737 |
| 157 | Ubrogepant (Ubrelvy) | $100.6M | 75,781 |
| 158 | Darunavir/Cobicistat (Prezcobix) | $99.7M | 38,374 |
| 159 | Tocilizumab (Actemra) | $99.5M | 24,891 |
| 160 | Omalizumab (Xolair) | $98.9M | 30,451 |
| 161 | Brimonidine Tartrate (Alphagan P) | $98.8M | 988,570 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology